Inogen (NASDAQ: INGN) holders back equity plan but keep staggered board
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Inogen, Inc. reported results of its annual stockholder meeting and changes to its equity compensation plan. Stockholders approved an Amended and Restated 2023 Equity Incentive Plan that increases the shares of common stock available for awards by an additional 750,000 shares, effective upon approval.
Two Class III directors, Glenn Boehnlein and Mira Sahney, were re-elected, and Deloitte & Touche LLP was ratified as independent auditor for the year ending December 31, 2026. Stockholders approved executive compensation on an advisory basis and the equity plan, while an amendment to declassify the board was not approved. About 20,844,941 of 27,324,616 entitled shares were represented, a turnout of approximately 76.28%.
Positive
- None.
Negative
- None.
Insights
Routine meeting actions with modest added equity overhang.
Inogen obtained stockholder approval to expand its 2023 equity incentive plan by 750,000 shares, supporting continued use of stock-based compensation. Director elections, auditor ratification, and say-on-pay all passed with strong support, indicating general alignment between management and stockholders.
The amendment to declassify the board did not receive the required approval, so the staggered board structure remains. Around 76.28% of entitled shares were represented, showing solid participation. Overall, these outcomes reflect routine governance decisions with incremental potential dilution from the larger equity plan.
8-K Event Classification
3 items: 5.02, 5.07, 9.01
3 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Equity plan share increase: 750,000 shares
Shares entitled to vote: 27,324,616 shares
Shares represented at meeting: 20,844,941 shares
+4 more
7 metrics
Equity plan share increase
750,000 shares
Additional common stock available under Amended and Restated 2023 Equity Incentive Plan
Shares entitled to vote
27,324,616 shares
Common stock entitled to vote as of April 6, 2026
Shares represented at meeting
20,844,941 shares
Shares present or by proxy at annual meeting (~76.28%)
Turnout percentage
76.28%
Percentage of outstanding common stock represented at the annual meeting
Equity plan approval votes
16,208,966 for / 2,009,937 against
Stockholder vote on Amended and Restated 2023 Equity Incentive Plan
Auditor ratification votes
20,395,716 for / 407,035 against
Ratification of Deloitte & Touche LLP for 2026 fiscal year
Declassify board votes for
17,883,761 votes
Votes for amendment to declassify the board (not approved)
Key Terms
Amended and Restated 2023 Equity Incentive Plan, broker non-votes, advisory, non-binding basis, independent registered public accounting firm, +1 more
5 terms
Amended and Restated 2023 Equity Incentive Plan financial
"the Company’s stockholders approved the adoption of the Company’s Amended and Restated 2023 Equity Incentive Plan"
broker non-votes financial
"The votes regarding the proposal were as follows ... Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
advisory, non-binding basis financial
"On an advisory, non-binding basis, the Company’s stockholders approved the named executive officers’ compensation"
independent registered public accounting firm financial
"the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
declassify the Board financial
"did not approve the amendment to the Company's Thirteenth Amended and Restated Certificate of Incorporation to declassify the Board"
Declassify the board means changing a company's board of directors from a staggered setup—where only a portion of directors face election each year—to a structure where all directors are elected annually. For investors this matters because it makes the board more directly accountable and responsive, like replacing a multi-year rotating club leadership with yearly elections, and it can speed corporate change or make hostile takeovers easier to pursue.
FAQ
What equity plan change did Inogen (INGN) stockholders approve?
Stockholders approved the Amended and Restated 2023 Equity Incentive Plan, adding 750,000 shares of common stock for future awards. This expansion supports continued use of stock options and restricted stock units as part of Inogen’s employee and executive compensation programs.
Were Inogen’s Class III director nominees elected at the 2026 meeting?
Yes. Glenn Boehnlein received 17,324,463 votes for and Mira Sahney received 13,276,829 votes for, with broker non-votes on each. Both were elected as Class III directors to serve until Inogen’s 2029 annual meeting or until successors are elected.
Did Inogen (INGN) stockholders ratify the company’s independent auditor?
Yes. Stockholders ratified Deloitte & Touche LLP as Inogen’s independent registered public accounting firm for the year ending December 31, 2026, with 20,395,716 votes for, 407,035 votes against, and 42,190 abstentions recorded on the proposal.
How did Inogen stockholders vote on executive compensation in 2026?
On an advisory, non-binding basis, stockholders approved the compensation of Inogen’s named executive officers. The proposal received 17,316,134 votes for, 921,787 votes against, 35,304 abstentions, and 2,571,716 broker non-votes, reflecting broad but not unanimous support.
Was the proposal to declassify Inogen’s board of directors approved?
No. The amendment to Inogen’s Thirteenth Amended and Restated Certificate of Incorporation to declassify the board was not approved. Voting results showed 17,883,761 votes for, 154,379 against, 235,085 abstentions, and 2,571,716 broker non-votes on this governance change.